Incidence and Clinical Features of Early Stent Thrombosis in the Era of New P2y12 Inhibitors (PLATIS-2)

Elad Asher; Arsalan Abu-Much; Ilan Goldenberg; Amit Segev; Avi Sabbag; Israel Mazin; Meital Shlezinger; Shaul Atar; Doron Zahger; Arthur Polak; Roy Beigel; Shlomi Matetzky; Platelets and Thrombosis in Sheba-PLATIS Study Group

doi:10.1371/journal.pone.0157437

Loading metrics

Open Access

Peer-reviewed

Research Article

Incidence and Clinical Features of Early Stent Thrombosis in the Era of New P2y12 Inhibitors (PLATIS-2)

Elad Asher ,

* E-mail: el.asher@gmail.com

Affiliation Leviev Heart Center, Sheba Medical Center, Tel Hashomer, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⨯
Arsalan Abu-Much,

Affiliation Leviev Heart Center, Sheba Medical Center, Tel Hashomer, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⨯
Ilan Goldenberg,

Affiliation Leviev Heart Center, Sheba Medical Center, Tel Hashomer, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⨯
Amit Segev,

Affiliation Leviev Heart Center, Sheba Medical Center, Tel Hashomer, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⨯
Avi Sabbag,

Affiliation Leviev Heart Center, Sheba Medical Center, Tel Hashomer, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⨯
Israel Mazin,

Affiliation Leviev Heart Center, Sheba Medical Center, Tel Hashomer, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⨯
Meital Shlezinger,

Affiliation Leviev Heart Center, Sheba Medical Center, Tel Hashomer, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⨯
Shaul Atar,

Affiliation Division of Cardiology, Galilee Medical Center, Nahariya, Israel
⨯
Doron Zahger,

Affiliation Department of Cardiology, Soroka Medical Center, Beer Sheba, Israel
⨯
Arthur Polak,

Affiliation Heart Institute, Hadassah University Hospital, Jerusalem, Israel
⨯
Roy Beigel,

Affiliation Leviev Heart Center, Sheba Medical Center, Tel Hashomer, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⨯
Shlomi Matetzky,

Affiliation Leviev Heart Center, Sheba Medical Center, Tel Hashomer, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⨯
Platelets and Thrombosis in Sheba-PLATIS Study Group

¶Membership of the Platelets and Thrombosis in Sheba-PLATIS Study Group is provided in the Acknowledgments.
⨯

Incidence and Clinical Features of Early Stent Thrombosis in the Era of New P2y12 Inhibitors (PLATIS-2)

Elad Asher,
Arsalan Abu-Much,
Ilan Goldenberg,
Amit Segev,
Avi Sabbag,
Israel Mazin,
Meital Shlezinger,
Shaul Atar,
Doron Zahger,
Arthur Polak

Published: June 16, 2016
https://doi.org/10.1371/journal.pone.0157437

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Antiplatelet therapy
Is the Subject Area "Antiplatelet therapy" applicable to this article?

Thanks for your feedback.
Thrombosis
Is the Subject Area "Thrombosis" applicable to this article?

Thanks for your feedback.
Coronary stenting
Is the Subject Area "Coronary stenting" applicable to this article?

Thanks for your feedback.
Stent implantation
Is the Subject Area "Stent implantation" applicable to this article?

Thanks for your feedback.
Myocardial infarction
Is the Subject Area "Myocardial infarction" applicable to this article?

Thanks for your feedback.
Coronary angioplasty
Is the Subject Area "Coronary angioplasty" applicable to this article?

Thanks for your feedback.
Coronary heart disease
Is the Subject Area "Coronary heart disease" applicable to this article?

Thanks for your feedback.
Receptor antagonist therapy
Is the Subject Area "Receptor antagonist therapy" applicable to this article?

Thanks for your feedback.